Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects.
Kanter J, Smith WR, Desai PC, Treadwell M, Andemariam B, Little J, Nugent D, Claster S, Manwani DG, Baker J, Strouse JJ, Osunkwo I, Stewart RW, King A, Shook LM, Roberts JD, Lanzkron S. Kanter J, et al. Among authors: andemariam b. Blood Adv. 2020 Aug 25;4(16):3804-3813. doi: 10.1182/bloodadvances.2020001743. Blood Adv. 2020. PMID: 32785684 Free PMC article.
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.
Antwi-Boasiako C, Andemariam B, Colombatti R, Asare EV, Strunk C, Piccone CM, Manwani D, Boruchov D, Farooq F, Urbonya R, Wilson S, Boatemaa GD, Perrotta S, Sainati L, Rivers A, Rao S, Zempsky W, Ekem I, Sey F, Segbefia C, Inusa B, Tartaglione I, Campbell AD. Antwi-Boasiako C, et al. Among authors: andemariam b. Ann Hematol. 2020 Sep;99(9):2073-2079. doi: 10.1007/s00277-020-04057-8. Epub 2020 May 6. Ann Hematol. 2020. PMID: 32377816 Free PMC article.
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research.
Campbell AD, Colombatti R, Andemariam B, Strunk C, Tartaglione I, Piccone CM, Manwani D, Asare EV, Boruchov D, Farooq F, Urbonya R, Boatemaa GD, Perrotta S, Sainati L, Rivers A, Rao S, Zempsky W, Sey F, Segbefia C, Inusa B, Antwi-Boasiako C. Campbell AD, et al. Among authors: andemariam b. J Racial Ethn Health Disparities. 2021 Feb;8(1):99-106. doi: 10.1007/s40615-020-00762-2. Epub 2020 May 16. J Racial Ethn Health Disparities. 2021. PMID: 32418182 Free PMC article.
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
Osunkwo I, Andemariam B, Minniti CP, Inusa BPD, El Rassi F, Francis-Gibson B, Nero A, Trimnell C, Abboud MR, Arlet JB, Colombatti R, de Montalembert M, Jain S, Jastaniah W, Nur E, Pita M, DeBonnett L, Ramscar N, Bailey T, Rajkovic-Hooley O, James J. Osunkwo I, et al. Among authors: andemariam b. Am J Hematol. 2021 Apr 1;96(4):404-417. doi: 10.1002/ajh.26063. Epub 2021 Feb 25. Am J Hematol. 2021. PMID: 33264445 Free PMC article.
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.
Tartaglione I, Strunk C, Antwi-Boasiako C, Andemariam B, Colombatti R, Asare EV, Piccone CM, Manwani D, Boruchov D, Tavernier F, Farooq F, Akatue S, Oteng B, Urbonya R, Wilson S, Owda A, Bamfo R, Boatemaa GD, Rao S, Zempsky W, Sey F, Inusa BP, Perrotta S, Segbefia C, Campbell AD. Tartaglione I, et al. Among authors: andemariam b. Blood Cells Mol Dis. 2021 May;88:102531. doi: 10.1016/j.bcmd.2020.102531. Epub 2021 Jan 2. Blood Cells Mol Dis. 2021. PMID: 33401140
Kneeling Was the First Step for Sickle Cell Disease.
Desai P, Little J, Kanter J, Bridges K, Andemariam B, Lanzkron S. Desai P, et al. Among authors: andemariam b. Ann Intern Med. 2021 Jul;174(7):1004-1005. doi: 10.7326/M20-7418. Epub 2021 Mar 23. Ann Intern Med. 2021. PMID: 33750189 No abstract available.
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort.
Strunk C, Tartaglione I, Piccone CM, Colombatti R, Andemariam B, Manwani D, Smith A, Haile H, Kim E, Wilson S, Asare EV, Rivers A, Farooq F, Urbonya R, Boruchov D, Boatemaa GD, Perrotta S, Ekem I, Sainati L, Rao S, Zempsky W, Sey F, Antwi-Boasiako C, Segbefia C, Inusa B, Campbell AD. Strunk C, et al. Among authors: andemariam b. Blood Cells Mol Dis. 2021 Dec;92:102612. doi: 10.1016/j.bcmd.2021.102612. Epub 2021 Sep 21. Blood Cells Mol Dis. 2021. PMID: 34564050 Free PMC article.
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana.
Zempsky WT, Yanaros M, Sayeem M, Boruchov D, Piccone CM, Manwani D, Strunk C, Tartaglione I, Colombatti R, Akatue S, Oteng B, Owda A, Bamfo R, Wilson S, Rivers A, Farooq F, Urbonya R, Boatemaa GD, Rao S, Inusa B, Antwi-Boasiako C, Segbefia C, Sey F, Andemariam B, Asare EV, Campbell AD. Zempsky WT, et al. Among authors: andemariam b. Pain Med. 2022 Aug 1;23(8):1379-1386. doi: 10.1093/pm/pnac023. Pain Med. 2022. PMID: 35166851
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.
Osunkwo I, James J, El-Rassi F, Nero A, Minniti CP, Trimnell C, Paulose J, Ramscar N, Bailey T, Rajkovic-Hooley O, Andemariam B. Osunkwo I, et al. Among authors: andemariam b. Am J Hematol. 2022 Aug;97(8):1055-1064. doi: 10.1002/ajh.26576. Epub 2022 Jun 20. Am J Hematol. 2022. PMID: 35472249 Free PMC article.
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises.
Segbefia C, Campbell J, Tartaglione I, Asare EV, Andemariam B, Zempsky W, Colombatti R, Boatemaa GD, Boruchov D, Rao S, Piccone CM, Smith A, Haile H, Kim E, Wilson S, Farooq F, Urbonya R, Rivers A, Manwani D, Gai J, Sey F, Inusa B, Antwi-Boasiako C, Strunk C, Campbell AD. Segbefia C, et al. Among authors: andemariam b. J Womens Health (Larchmt). 2023 Dec;32(12):1284-1291. doi: 10.1089/jwh.2023.0023. Epub 2023 Nov 23. J Womens Health (Larchmt). 2023. PMID: 38011013 Free PMC article.
Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.
Szczepanek SM, Roberts S, Rogers K, Cotte C, Adami AJ, Bracken SJ, Salmon S, Secor ER Jr, Thrall RS, Andemariam B, Metzger DW. Szczepanek SM, et al. Among authors: andemariam b. PLoS One. 2016 Feb 24;11(2):e0149261. doi: 10.1371/journal.pone.0149261. eCollection 2016. PLoS One. 2016. PMID: 26910228 Free PMC article.
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
Piel FB, Rees DC, DeBaun MR, Nnodu O, Ranque B, Thompson AA, Ware RE, Abboud MR, Abraham A, Ambrose EE, Andemariam B, Colah R, Colombatti R, Conran N, Costa FF, Cronin RM, de Montalembert M, Elion J, Esrick E, Greenway AL, Idris IM, Issom DZ, Jain D, Jordan LC, Kaplan ZS, King AA, Lloyd-Puryear M, Oppong SA, Sharma A, Sung L, Tshilolo L, Wilkie DJ, Ohene-Frempong K. Piel FB, et al. Among authors: andemariam b. Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11. Lancet Haematol. 2023. PMID: 37451304 Free PMC article. Review.
Global burden of transfusion in sickle cell disease.
Inusa BP, Atoyebi W, Andemariam B, Hourani JN, Omert L. Inusa BP, et al. Among authors: andemariam b. Transfus Apher Sci. 2023 Oct;62(5):103764. doi: 10.1016/j.transci.2023.103764. Epub 2023 Jul 17. Transfus Apher Sci. 2023. PMID: 37541800 Free article. Review.
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.
Herring WL, Gallagher ME, Shah N, Morse KC, Mladsi D, Dong OM, Chawla A, Leiding JW, Zhang L, Paramore C, Andemariam B. Herring WL, et al. Among authors: andemariam b. Pharmacoeconomics. 2024 Jun;42(6):693-714. doi: 10.1007/s40273-024-01385-9. Epub 2024 Apr 29. Pharmacoeconomics. 2024. PMID: 38684631 Free PMC article.
Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.
Swede H, Sarwar A, Magge A, Braithwaite D, Cook LS, Gregorio DI, Jones BA, R Hoag J, Gonsalves L, L Salner A, Zarfos K, Andemariam B, Stevens RG, G Dugan A, Pensa M, A Brockmeyer J. Swede H, et al. Among authors: andemariam b. Cancer Causes Control. 2016 May;27(5):627-36. doi: 10.1007/s10552-016-0736-3. Epub 2016 Mar 21. Cancer Causes Control. 2016. PMID: 27000206 Free PMC article.
New therapies for immune thrombocytopenic purpura.
Andemariam B, Bussel J. Andemariam B, et al. Curr Opin Hematol. 2007 Sep;14(5):427-31. doi: 10.1097/MOH.0b013e3282a4a68b. Curr Opin Hematol. 2007. PMID: 17934347 Review.
Novel thrombopoietic agents.
Andemariam B, Psaila B, Bussel JB. Andemariam B, et al. Hematology Am Soc Hematol Educ Program. 2007:106-13. doi: 10.1182/asheducation-2007.1.106. Hematology Am Soc Hematol Educ Program. 2007. PMID: 18024617 Review.
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.
Idowu M, Otieno L, Dumitriu B, Lobo CLC, Thein SL, Andemariam B, Nnodu OE, Inati A, Glaros AK, Bartolucci P, Colombatti R, Taher AT, Abboud MR, Darbari D, Ataga KI, Antmen AB, Kuo KHM, de Souza Medina S, Oluyadi A, Iyer V, Morris S, Yates AM, Shao H, Patil S, Urbstonaitis R, Zaidi AU, Gheuens S, Smith WR. Idowu M, et al. Among authors: andemariam b. Lancet Haematol. 2024 Dec 4:S2352-3026(24)00319-3. doi: 10.1016/S2352-3026(24)00319-3. Online ahead of print. Lancet Haematol. 2024. PMID: 39644907
54 results